role="main" class="main-container container js-quickedit-main-content" id="main-content">

Bill 117, Myasthenia Gravis Month Act, 2022

Walker, Bill

Taylor, Monique

Royal Assent received. Statutes of Ontario 2022,

chapter 14

Please select

View bill

Status

Debates

Royal Assent

Original

Bill 117 Royal Assent (PDF)

EXPLANATORY

NOTE

This Explanatory Note was written as a reader’s

aid to Bill 117 and does not form part of the law.

Bill 117 has been enacted as

Chapter 14 of the Statutes of Ontario, 2022.

The

Bill proclaims the month of June in each year as Myasthenia Gravis Month.

Bill 117 2022

Act to proclaim the month of June as Myasthenia Gravis Month

Preamble

Myasthenia

Gravis is a chronic autoimmune disorder in which antibodies destroy the

communication between nerves and muscle, resulting in weakness of the skeletal

muscles. The disorder affects the voluntary muscles of the body, especially

those that control the eyes, mouth, throat and limbs. A Myasthenia Gravis

crisis can involve difficulty in swallowing or breathing. The following are the

most common symptoms of Myasthenia Gravis:

1. Visual

problems, including drooping eyelids (ptosis) and double vision (diplopia).

2. Muscle

weakness and fatigue that may vary rapidly in intensity over days or even hours

and worsen as muscles are used (early fatigue).

3. Facial

muscle involvement causing a mask-like appearance; a smile may appear more like

a snarl.

4. Trouble

swallowing or pronouncing words.

5. Weakness

of the neck or limbs.

Myasthenia Gravis is not inherited and it is

not contagious; it is caused when antibodies attack receptors on muscle thereby

blocking a chemical needed to stimulate muscle contraction.

is estimated that there are 26.3 cases of Myasthenia Gravis per 100,000 people

in Ontario, meaning this disorder impacts more than 3,800 Ontario residents.

The

disorder can strike anyone at any age, but is more frequently seen in young

women between the age 20 and 30 and in men aged 50 and older. The cause of

Myasthenia Gravis is unknown and there is no cure, but early detection and

prompt medical management can help people live longer, more functional lives.

Therefore,

Her Majesty, by and with the advice and consent of the Legislative Assembly of

the Province of Ontario, enacts as follows:

Myasthenia

Gravis Month

The

month of June in each year is proclaimed as Myasthenia Gravis Month.

Commencement

This Act comes into force on the day it receives Royal Assent.

Short

title

The

short title of this Act is the Myasthenia Gravis Month

Act, 2022 .

Bill 117 Original (PDF)

EXPLANATORY

NOTE

The

Bill proclaims the month of June in each year as Myasthenia Gravis Month.

Bill 117 2022

Act to proclaim the month of June as Myasthenia Gravis Month

Preamble

Myasthenia

Gravis is a chronic autoimmune disorder in which antibodies destroy the

communication between nerves and muscle, resulting in weakness of the skeletal

muscles. The disorder affects the voluntary muscles of the body, especially

those that control the eyes, mouth, throat and limbs. A Myasthenia Gravis

crisis can involve difficulty in swallowing or breathing. The following are the

most common symptoms of Myasthenia Gravis:

1. Visual

problems, including drooping eyelids (ptosis) and double vision (diplopia).

2. Muscle

weakness and fatigue that may vary rapidly in intensity over days or even hours

and worsen as muscles are used (early fatigue).

3. Facial

muscle involvement causing a mask-like appearance; a smile may appear more like

a snarl.

4. Trouble

swallowing or pronouncing words.

5. Weakness

of the neck or limbs.

Myasthenia Gravis is not inherited and it is

not contagious; it is caused when antibodies attack receptors on muscle thereby

blocking a chemical needed to stimulate muscle contraction.

is estimated that there are 26.3 cases of Myasthenia Gravis per 100,000 people

in Ontario, meaning this disorder impacts more than 3,800 Ontario residents.

The

disorder can strike anyone at any age, but is more frequently seen in young

women between the age 20 and 30 and in men aged 50 and older. The cause of

Myasthenia Gravis is unknown and there is no cure, but early detection and

prompt medical management can help people live longer, more functional lives.

Therefore,

Her Majesty, by and with the advice and consent of the Legislative Assembly of

the Province of Ontario, enacts as follows:

Myasthenia

Gravis Month

The

month of June in each year is proclaimed as Myasthenia Gravis Month.

Commencement

This Act comes into force on the day it receives Royal Assent.

Short

title

The

short title of this Act is the Myasthenia Gravis Month

Act, 2022 .

Date Bill stage Event Outcome Committee

April 14, 2022

Royal Assent

Royal Assent received

April 13, 2022

Third Reading

Vote

Carried

April 13, 2022

Third Reading

Debated

April 13, 2022

Second Reading

Ordered for Third Reading pursuant to the Order of the House

April 13, 2022

Second Reading

Vote

Carried

April 13, 2022

Second Reading

Debated

April 13, 2022

First Reading

Vote

Carried

Debates and Progress

First Reading

April 13, 2022

Committee

Second Reading

April 13, 2022

Mr. Bill Walker, Miss Monique Taylor, Hon. Paul Calandra

Carried. Ordered for Third Reading.

Committee

Third Reading

April 13, 2022

Mr. Bill Walker, Miss Monique Taylor.

Carried.

Royal Assent

Thursday, April 14, 2022

Was this page helpful? Yes , I found this page helpful. An optional survey will open in a new tab. No , I didn’t find this page helpful. An optional survey will open in a new tab.

Back to top